文献速递神经创伤神经重症

创伤性轴索损伤的血清评估:GFAP、t-Tau、UCH-L1和NfL水平与弥散张量成像指标的相关性及其预后价值

Serum assessment of traumatic axonal injury: the correlation of GFAP, t-Tau, UCH-L1, and NfL levels with diffusion tensor imaging metrics and its prognosis utility.
PubMed 文献 · J Neurosurg · 2022-07-15

该前瞻性研究纳入2016至2021年87例各严重程度创伤性脑损伤患者,伤后24小时内采血并用Simoa检测GFAP、t-Tau、UCH-L1和NfL,分析其与胼胝体病灶体积及部分各向异性(FA)的关系及预后价值。结果显示UCH-L1和NfL似乎对检测创伤性轴索损伤更具特异性,NfL联合胼胝体FA可能有助于预测远期结局。

要点

  • UCH-L1和NfL似乎是对检测创伤性轴索损伤更具特异性的生物标志物。
  • 胼胝体FA是影响UCH-L1和NfL水平的独立因素。
  • NfL与胼胝体FA是结局的独立互补因素,联合可能有助于预测远期结局。

核心结论

  • UCH-L1和NfL似乎是对检测创伤性轴索损伤更具特异性的生物标志物。
  • NfL浓度联合胼胝体FA可能有助于预测远期结局。

研究设计与样本

  • 前瞻性纳入2016至2021年各严重程度创伤性脑损伤患者87例,伤后24小时内采血并完成包括DTI在内的影像评估。
  • 采用超灵敏Simoa多重检测 panel 测定GFAP、t-Tau、UCH-L1和NfL血清浓度,伤后6个月评定GOSE评分。
  • 采用非参数检验分析生物标志物浓度与胼胝体病灶体积分析及FA的关系,通过C统计量和有序回归分析评估预后价值。

主要发现

  • 所有生物标志物浓度在患者中均显著高于对照。
  • 生物标志物浓度受占位性病灶存在影响,但胼胝体FA是影响UCH-L1和NfL水平的独立因素,使这两个标志物成为TAI更好的替代指标。
  • 生物标志物在判定将出现不良结局的患者方面表现良好。
  • NfL与胼胝体FA是结局的独立互补因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Diagnosis of traumatic axonal injury (TAI) is challenging because of its underestimation by conventional MRI and the technical requirements associated with the processing of diffusion tensor imaging (DTI). Serum biomarkers seem to be able to identify patients with abnormal CT scanning findings, but their potential role to assess TAI has seldomly been explored. METHODS: Patients with all severities of traumatic brain injury (TBI) were prospectively included in this study between 2016 and 2021. They underwent blood extraction within 24 hours after injury and imaging assessment, including DTI. Serum concentrations of glial fibrillary acidic protein, total microtubule-associated protein (t-Tau), ubiquitin C-terminal hydrolase L1 (UCH-L1), and neurofilament light chain (NfL) were measured using an ultrasensitive Simoa multiplex assay panel, a digital form of enzyme-linked immunosorbent assay. The Glasgow Outcome Scale-Extended score was determined at 6 months after TBI. The relationships between biomarker concentrations, volumetric analysis of corpus callosum (CC) lesions, and fractional anisotropy (FA) were analyzed by nonparametric tests. The prognostic utility of the biomarker was determined by calculating the C-statistic and an ordinal regression analysis. RESULTS: A total of 87 patients were included. Concentrations of all biomarkers were significantly higher for patients compared with controls. Although the concentration of the biomarkers was affected by the presence of mass lesions, FA of the CC was an independent factor influencing levels of UCH-L1 and NfL, which positioned these two biomarkers as better surrogates of TAI. Biomarkers also performed well in determining patients who would have had unfavorable outcome. NfL and the FA of the CC are independent complementary factors related to outcome. CONCLUSIONS: UCH-L1 and NfL seem to be the biomarkers more specific to detect TAI. The concentration of NfL combined with the FA of the CC might help predict long-term outcome.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Castaño-Leon AM, Sánchez Carabias C, Hilario A, et al. Serum assessment of traumatic axonal injury: the correlation of GFAP, t-Tau, UCH-L1, and NfL levels with diffusion tensor imaging metrics and its prognosis utility. J Neurosurg. 2022. PMID: 35901687. doi:10.3171/2022.5.JNS22638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。